Recurrent Pregnancy Loss (RPL) in Hyderabad (Telangana): Causes, Diagnosis & Evidence-Based Treatment

Recurrent pregnancy loss is defined by most international bodies, including the American Society for Reproductive Medicine (ASRM) and the Royal College of Obstetricians and Gynaecologists (RCOG), as two or more clinical pregnancy losses. In India, the Indian Society for Assisted Reproduction broadly aligns with this definition, though many Hyderabad-based specialists initiate investigations after two losses rather than waiting for a third.

It is important to distinguish RPL from infertility. Couples with RPL can typically conceive — the challenge lies in sustaining the pregnancy. This distinction directly shapes the diagnostic approach. A biochemical pregnancy (a very early loss detected only by a blood hCG test) may or may not be counted depending on the clinical context, and couples should clarify this with their HomeIVF specialist.

In Hyderabad's urban and peri-urban populations, late presentation is common due to social stigma and the assumption that pregnancy loss is 'normal.' The HomeIVF Medical Board emphasises that no pregnancy loss should be dismissed without at least a basic evaluation, especially when it recurs. Early investigation saves couples months — sometimes years — of unnecessary heartbreak.

The causes of RPL are multifactorial, and in a significant proportion of couples, more than one contributing factor is identified. The most common categories include:

**Genetic and Chromosomal Factors:** Embryonic aneuploidy (abnormal chromosome number) is the single largest cause. Parental chromosomal rearrangements — such as balanced translocations — are found in 3–5% of RPL couples and carry a high recurrence risk without intervention.

**Uterine Structural Abnormalities:** Septate uterus, submucous fibroids, intrauterine adhesions (Asherman's syndrome), and bicornuate uterus collectively account for 10–15% of RPL cases. Women from Warangal and rural Telangana often present with undiagnosed uterine anomalies due to limited prior imaging.

**Thrombophilic and Immunological Disorders:** Antiphospholipid syndrome (APS) is the most important treatable immunological cause, found in 10–15% of patients. Inherited thrombophilias (Factor V Leiden, MTHFR mutations) are also screened routinely.

**Endocrine Disorders:** Uncontrolled hypothyroidism, elevated prolactin, poorly managed diabetes, and polycystic ovarian syndrome (PCOS) — highly prevalent in Hyderabad's population — are all implicated in RPL.

**Unexplained RPL:** In 25–50% of thoroughly investigated couples, no definitive cause is found. Even in this group, supportive care and close monitoring significantly improve outcomes.

Recurrent pregnancy loss does not always present with dramatic symptoms, which is why many couples — especially in Secunderabad and outer Hyderabad — delay seeking specialist care. Understanding the warning signs allows for earlier intervention.

The most direct indicator is two or more confirmed pregnancy losses. However, several accompanying symptoms and patterns should prompt immediate RPL evaluation:

**Irregular or very light periods** before and between pregnancies may signal uterine adhesions or hormonal imbalance. **Recurrent spotting in early pregnancy** — even before an ultrasound confirms viability — warrants urgent investigation. **A personal or family history of blood clotting disorders**, deep vein thrombosis, or autoimmune conditions (like lupus) is a significant red flag for APS or thrombophilia.

**Late losses (after 10 weeks)** are particularly important to evaluate, as these are more likely linked to uterine structural problems, APS, or cervical incompetence rather than random chromosomal errors.

Women with PCOS — a condition disproportionately prevalent in Telangana — face elevated RPL risk due to elevated LH, insulin resistance, and suboptimal endometrial environment. Any woman with known PCOS and even one pregnancy loss should discuss RPL screening with a HomeIVF-affiliated specialist.

The right time to seek specialist input is earlier than most couples realise. The HomeIVF Medical Board recommends consulting an RPL specialist in Hyderabad under the following circumstances:

— After **two consecutive pregnancy losses** at any gestational age, even very early biochemical losses. — After **one loss at or beyond 10 weeks**, given the higher likelihood of an identifiable structural or immunological cause. — If you have **known risk factors** such as PCOS, thyroid disorders, antiphospholipid antibodies, or a family history of clotting disorders. — If previous losses were associated with **fetal heartbeat detected and then lost** — a particularly distressing pattern that warrants immediate immunological and anatomical evaluation. — If you are **over 35 years of age** and have experienced even one loss, given the higher baseline chromosomal risk and narrower treatment window.

In Hyderabad, Secunderabad, and Warangal, HomeIVF's tele-consultation model means couples no longer need to take half-day leave from work to sit in a hospital queue. A structured first consultation — including review of all prior records — can be completed from home within 48 hours of booking.

A comprehensive RPL workup is not a single test — it is a structured, sequential panel designed to systematically rule in or out known causes. The HomeIVF Medical Board-approved RPL panel for Hyderabad patients includes:

**Genetic Testing:** Parental karyotype (both partners), and where available, products of conception (POC) karyotype from a prior loss. Next-generation sequencing (NGS)-based POC analysis is increasingly available in Hyderabad's reference laboratories.

**Uterine Evaluation:** 3D transvaginal ultrasound is the first-line tool. Saline infusion sonography (SIS) or hysteroscopy is added where intrauterine pathology is suspected. MRI may be used for complex Müllerian anomalies.

**Immunological and Thrombophilia Panel:** Anticardiolipin antibodies (IgG and IgM), anti-β2 glycoprotein-I antibodies, lupus anticoagulant, Factor V Leiden mutation, MTHFR mutation, Protein C and S levels.

**Endocrine Assessment:** TSH (targeting < 2.5 mIU/L in women planning pregnancy), fasting insulin, fasting glucose, prolactin, AMH, Day 2–3 FSH and LH.

**Sperm DNA Fragmentation:** Increasingly recognised as a contributor to RPL; sperm DNA fragmentation index (DFI) > 25–30% is associated with higher early loss rates.

HomeIVF coordinates home sample collection for most blood-based tests through partner labs in Hyderabad, Secunderabad, and Warangal, eliminating the logistical burden of multiple hospital visits.

Treatment is directly guided by the identified cause, and the HomeIVF Medical Board ensures every protocol is evidence-based and internationally benchmarked.

**For Chromosomal Causes:** Preimplantation Genetic Testing for Aneuploidies (PGT-A) during IVF cycles significantly improves live birth rates by transferring only chromosomally normal embryos. For couples with parental translocations, PGT-SR (structural rearrangements) is recommended. IVF packages starting from ₹1.5 lakh are available through HomeIVF for Hyderabad patients, inclusive of monitoring consultations.

**For Uterine Abnormalities:** Hysteroscopic septum resection, adhesiolysis, or myomectomy (for submucous fibroids) is coordinated through HomeIVF's network of surgical partners in Hyderabad. Post-operative endometrial recovery is monitored with home-based ultrasound follow-up.

**For APS and Thrombophilia:** Low-molecular-weight heparin (LMWH) combined with low-dose aspirin is the evidence-based standard of care, initiated from the time of a positive pregnancy test. HomeIVF nurses provide injection training and home administration support.

**For Endocrine Causes:** Thyroid optimisation, metformin for insulin resistance in PCOS, and bromocriptine for hyperprolactinaemia are initiated and monitored remotely.

**For Unexplained RPL:** Progesterone supplementation (vaginal micronised progesterone) from the luteal phase, intensive early pregnancy monitoring, and psychological support are offered as a structured 'supportive care' package — shown in the PRISM trial to improve live birth rates in women with unexplained RPL and prior bleeding.

One of the most significant advances HomeIVF has brought to Telangana is the ability to conduct high-frequency early pregnancy monitoring without requiring patients to travel to a clinic every few days. For RPL patients, early pregnancy — typically weeks 5 through 12 — is a period of intense anxiety and clinical need.

HomeIVF's home-monitoring model delivers:

**Doorstep Blood Tests:** Serial serum hCG and progesterone measurements during early pregnancy, with results reviewed by a HomeIVF Medical Board-affiliated specialist within hours. This allows rapid detection of pregnancies not progressing normally and timely intervention.

**Home Ultrasound Coordination:** In Hyderabad and Secunderabad, HomeIVF coordinates home-visit ultrasound services or partners with walk-in imaging centres with priority scheduling, eliminating two-to-three-hour waits.

**Medication Adherence Support:** For patients on LMWH injections, progesterone pessaries, or thyroid medication, HomeIVF's dedicated care coordinators conduct daily check-in calls during the critical first trimester, significantly improving adherence.

**Psychological Support Integration:** Grief after pregnancy loss is clinically significant. HomeIVF integrates counsellor access — available to patients across Warangal, Nizamabad, and Khammam — via teleconsultation, addressing the mental health dimension that traditional hospital systems often overlook.

This model is particularly transformative for working women in Hyderabad's IT corridor, where taking repeated half-days off for clinic visits is not always feasible.

Despite Hyderabad being one of India's top medical hubs, couples facing RPL in Telangana encounter real and consistent barriers to timely, comprehensive care.

**Fragmented Care:** Couples often visit a gynaecologist for the loss, a haematologist for clotting tests, and an endocrinologist for thyroid issues — with no single specialist synthesising the picture. HomeIVF provides a unified RPL care pathway, coordinated by the HomeIVF Medical Board, ensuring no test or finding falls through the cracks.

**Geographic Disparity:** Patients from Warangal, Nizamabad, Karimnagar, and Khammam frequently travel 100–200 km to Hyderabad for specialist consultations. HomeIVF's teleconsultation-first model means the initial workup, results review, and treatment planning happen online — a physical visit to Hyderabad is only required when surgery or egg retrieval is needed.

**Language and Communication Gaps:** The HomeIVF platform supports Telugu-language consultations, making it easier for couples from smaller towns across Telangana to clearly articulate their history and understand their treatment plan.

**Stigma and Delayed Presentation:** Social pressure to 'try again naturally' without investigation is common. HomeIVF's educational content — available in Telugu — helps couples understand that investigation is not a sign of giving up; it is a sign of taking control.

**Senior-Specialist Access:** HomeIVF does not replace senior specialists — it delivers senior-specialist care at home, bringing the same clinical expertise available in Hyderabad's top fertility hospitals directly to patients wherever they are in Telangana.